Singular Health Group Ltd

As of June 30, 2026, Singular Health Group Ltd carries a market capitalization of 71.23M, placing it among publicly traded companies globally. Its enterprise value stands at 61.28M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Singular Health Group Ltd's next confirmed earnings release is scheduled for February 19, 2027.

As of June 30, 2026, Singular Health Group Ltd has 323.77M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 48.14, and the price-to-book ratio stands at 6.76.

These figures are as of June 30, 2026. The EV/Sales ratio of 42.90 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 61.28M versus a market cap of 71.23M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Singular Health Group Ltd maintains a current ratio of 18.19, meaning it holds 18.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.04, indicating moderate leverage, while an interest coverage ratio of -723.84 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Singular Health Group Ltd posted a negative return on equity (ROE) of -53.66, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -49.84, reflecting losses generated across the asset base.

As of the close on October 22, 2026, Singular Health Group Ltd's stock has declined approximately 48.21% over the past 52 weeks. The 50-day moving average sits at 0.18, while the 200-day moving average is 0.21.

Over the twelve months ended June 30, 2026, Singular Health Group Ltd generated 1.43M in revenue and converted that into -6.34M in net income, yielding earnings per share of -0.02. EBITDA reached -7.17M, while operating income came in at -7.25M.

As of June 30, 2026, Singular Health Group Ltd holds 10.06M in cash and equivalents against 109,963.00 in total debt, resulting in a net debt position of -2.36M. Total book value stands at 10.54M, with working capital of 10.41M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The operating margin of -507.35 and net profit margin of -443.94 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Total shareholder yield is negative at -2.35, meaning Singular Health Group Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Singular Health Group Ltd has an Altman Z-Score of 56.47, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.